Abstract
Anxiety disorders (AD) are associated with an increase in physical comorbidities, but the effects of these diseases on hospital-based mortality are unclear. Consequently, we investigated whether the burden of physical comorbidity and its relevance on hospital-based mortality differed between individuals with and without AD during a 12.5-year observation period in general hospital admissions. During 1 January 2000 and 30 June 2012, 11,481 AD individuals were admitted to seven General Manchester Hospitals. All comorbidities with a prevalence ≥1 % were compared with those of 114,810 randomly selected and group-matched hospital controls of the same age and gender, regardless of priority of diagnoses or specialized treatments. Comorbidities that increased the risk of hospital-based mortality (but not mortality outside of the hospital) were identified using multivariate logistic regression analyses. AD individuals compared to controls had a substantial excess comorbidity, but a reduced hospital-based mortality rate. Twenty-two physical comorbidities were increased in AD individuals compared with controls, which included cardiovascular diseases and their risk factors. The most frequent physical comorbidities in AD individuals were hypertension, asthma, cataract, and ischaemic heart disease. Risk factors for hospital-based mortality in AD individuals were lung cancer, alcoholic liver disease, respiratory failure, heart failure, pneumonia, bronchitis, non-specific dementia, breast cancer, COPD, gallbladder calculus, atrial fibrillation, and angina. The impact of atrial fibrillation, angina, and gallbladder calculus on hospital-based mortality was higher in AD individuals than in controls. In contrast, other mortality risk factors had an equal or lower impact on hospital-based mortality in sample comparisons. Therefore AD individuals have a higher burden of physical comorbidity that is associated with a reduced risk of general hospital-based mortality. Atrial fibrillation, angina, and gallbladder calculus are major risk factors for general hospital-based mortality in AD individuals.
Similar content being viewed by others
References
Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA (2014) The global burden of anxiety disorders in 2010. Psychol Med 11:1–12
Michael T, Zetsche U, Margraf J (2007) Epidemiology of anxiety disorders. Psychiatry 6(4):136–142
Kessler RC, Aguilar-Gaxiola S, Alonso J et al (2009) The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psychiatr Soc 18:23–33
Andrews G, Henderson S, Hall W (2001) Relevance, comorbidity, disability and service utilization. Overview of the australian national mental health survey. Br J Psychiatry 178:145–153
Härter MC, Conway KP, Merikangas KR (2003) Associations between anxiety disorder and physical illness. Eur Arch Clin Neurosci 253(6):312–320
Sareen J, Jacobi F, Cox BJ, Belik SL, Clara I, Stein MB (2006) Disability and poor quality of life associated with comorbid anxiety disorder and physical conditions. Arch Intern Med 166:2109–2116
Roy-Byrne PP, Davidson KW, Kessler RC et al (2008) Anxiety disorder and comorbid medical illness. Gen Hosp Psychiatry 30:208–225
Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD (2012) Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ 345:e4933
Denollet J, Maas K, Knottnerus A, Keyzer JJ, Pop VJ (2009) Anxiety predicted premature all-cause and cardiovascular death in a 10-year follow-up of middle-aged women. J Clin Epidemiol 62:452–456
Chen YH, Tsai SY, Lee HC, Lin HC (2009) Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med 71:798–804
Chen YH, Hu CJ, Lee HC, Lin HC (2010) An increased risk of stroke among panic disorder patients: a 3-year follow-up study. Can J Psychiatry 55:43–49
Cheng YF, Leu HB, Su CC et al (2013) Association between panic disorder and risk of atrial fibrillation: a nationwide study. Psychosom Med 75:30–35
United Nations, Department of Economic and Social Affairs, Population Division (2012) Population Ageing and Development 2012. United Nations website. http://www.un.org/esa/population/publications/2012WorldPopAgeingDev_Chart/2012PopAgeingandDev_WallChart.pdf. Accessed: 26 September 2014
Campbell-Sills L, Stein MB, Sherbourne CD et al (2013) Effects of medical comorbidity on anxiety outcomes in primary care. Psychosom Med 75:713–720
George LM, Maddock K (1979) Accuracy of in-hospital activity notifications for infectious diseases. Br Med J 1:1332–1339
Schoepf D, Heun R, Weiffenbach O, Herrmann S, Maier W (2003) The 4-week prevalence of somatoform disorders and associated psychosocial impairment. Nervenarzt 74(3):245–251
Phung TK, Andersen BB, Høgh P, Kessing LV, Mortensen PB, Waldemar G (2007) Validity of dementia diagnoses in the Danish in-hospital registers. Dement Geriatr Cogn Disord 24(3):220–228
Schoepf D, Heun R (2014) Bipolar disorder and comorbidity: increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions. J Affect Disord 169:170–178
Schoepf D, Uppal H, Potluri R, Chandran S, Heun R (2014) Comorbidity and its relevance on general hospital-based mortality in major depressive disorder: a naturalistic 12-year follow-up in general hospital admissions. J Psychiatr Res 54:28–35
Schoepf D, Potluri R, Uppal H, Heun R (2014) Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 264(1):3–28
Schoepf D, Potluri R, Uppal H, Natalwala A, Heun R (2012) Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow up. Eur Psychiatry 27(1):33–42
Heun R, Schoepf D, Potluri R, Natalwala A (2013) Alzheimer’s disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry 28(1):40–48
Hirschfeld RMA (2001) The comorbidity of major depression and anxiety disorder: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 3:244–254
Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B (2007) Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 146(5):317–325
Atlantis E, Fahey P, Cochrane B, Smith S (2013) Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest. doi:10.1378/chest.12-1911
Holt RI, Phillips DIW, Jameson KA, Cooper C, Dennison EM, Peveler RC (2013) The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study. J Affect Disord 150(1):84–90
Mykletun A, Bjerkeset O, Overland S, Prince S, Dewey M, Stewart R (2009) Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry 195:118–125
Grasbeck A, Rorsman B, Hagnell O, Isberg PE (1996) Mortality of anxiety syndromes in a normal population: the Lundby study. Neuropsychobiology 33:118–126
Lane D, Carroll D, Ring C, Beevers DG, Lip GY (2001) Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 63:221–230
Lavretsky H, Mistry R, Bastani R et al (2003) Symptoms of depression and anxiety predict mortality in elderly veterans enrolled in the UPBEAT program. Int J Geriatr Psychiatry 18:183–184
Holwerda TJ, Schoevers RA, Dekker J, Deeg DJH, Jonker C, Beekman ATF (2007) The relationship between generalized anxiety disorder, depression and mortality in old age. Int J Geriatr Psychiatry 22:241–249
Herrmann C, Brand-Driehorst S, Buss U, Ruger U (2000) Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. J Psychosom Res 48:455–462
Lee WE, Wadsworth ME, Hotopf M (2006) The protective role of trait anxiety: a longitudinal cohort study. Psychol Med 36:345–351
Beary M, Hodgson R, Wildgust HJ (2012) A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol 26(5):52–61
Garin N, Olaya B, Perales J, Moneta MV, Miret M, Ayuso-Mateos JL, Haro JM (2014) Multimorbidity patterns in a national representative sample of the Spanish adult population. PLoS One 9(1):e84794. doi:10.1371/journal.pone.0084794
Kessler RC, Ormel J, Demler O, Stang PE (2003) Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med 45:1257–1266
Player MS, Peterson LE (2011) Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med 41(4):365–377
Rozanski A, Kubzansky LD (2005) Psychologic functioning and physical health: a paradigm of flexibility. Psychosom Med 67(Suppl 1):47–53
McCauley E, Katon W, Russo J, Richardson L, Lozano P (2007) Impact of anxiety and depression on functional impairment in adolescents with asthma. Gen Hosp Psychiatry 29(3):214–222
Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M (2006) What is worse for asthma control and quality of life: depressive disorders, anxiety disorder, or both? Chest 130:1039–1047
Evans DL, Charney DS, Lewis L et al (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189
Brown ES, Suppes T, Khan DA, Carmody TJ (2002) Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 22:55–61
Smoller JW, Simon NM, Pollack MH, Kradin R, Stern T (1999) Anxiety in patients with pulmonary disease: comorbidity and treatment. Semin Clin Neuropsychiatry 4(2):84–97
Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL (1996) Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 154(1):6–17
Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ (2012) Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125(6):773–781
Leske MC, Wu SY, Hennis A, Connel AM, Hyman L, Schachet A (1999) Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 106(1):35–41
Javadi MA, Zarel-Ghanavati S (2008) Cataracts in diabetic patients: a review article. J Opthalmic Vis Res 2(1):52–65
Eramudugolla R, Wood J, Anstey KJ (2013) Co-morbidity of depression and anxiety in common age-related eye diseases: a population based study of 662 adults. Front Aging Neurosci 5:1–9
Nattel S, Opie LH (2006) Controversies in atrial fibrillation. Lancet 367:262–272
Samokhvalov AV, Irving HM, Rehm J (2010) Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 17(6):706–712
Magnani JW, Rienstra M, Lin H et al (2011) Atrial fibrillation: current knowledge and future directions in epidemiology and genetics. Circulation 124:1982–1993
Eaker ED, Sullivan LM, Kelly-Hayes M, D`Agostino B, Benjamin EJ (2005) Tension and anxiety and the prediction of the 10 year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham offspring study. Psychosom Med 67(5):692–696
Patel D, McConkey ND, Sohaney R, McNeil A, Jedrzejczyk A, Armaganijan L (2013) A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol 2013(2013):1–11. Article ID 159850. doi:10.1155/2013/159850
Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Obermann A, Wong ND, Sheps D (2007) Panic attacks and risk of incident cardiovascular events in postmenopausal women in the women’s health initiative observational study. Arch Gen Psychiatry 64:1153–1160
Van Oudenhove L, Vandenberghe J, Geeraerts B, Vos R, Persoons P, Demyttenaere K, Fischler B, Tack J (2007) Relationship between anxiety and gastric sensimotor function in functional dyspepsia. Psychosom Med 69:455–463
Elixhauser A, Steiner C, Harris R, Coffey RM (1998) Comorbidity measures for use of administrative data. Med Care 36(1):8–27
Nicholson A, Kuper H, Hemingway H (2006) Depression as an etiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 27(23):2763–2774
Seldenrijk A, Vogelzangs N, van Oppen P, Penninx B, van Schaik A (2013) Depression, vascular conditions and chronicity. In: Schoepf D (Ed) Psychiatric disorders—new frontiers in affective disorders. InTech, pp 279-294.doi:10.5772/51623
Acknowledgments
We are extremely grateful to R. Potluri and H. Uppal for their support in provision, preparation of the data, and its analysis.
Conflict of interest
Both authors declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schoepf, D., Heun, R. Anxiety disorders and physical comorbidity: increased prevalence but reduced relevance of specific risk factors for hospital-based mortality during a 12.5-year observation period in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 265, 387–398 (2015). https://doi.org/10.1007/s00406-014-0566-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-014-0566-9